News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Analyst upgraded Centrus Energy to Buy after a pullback, recommending a tactical long.
  • Centrus's $4.5 billion backlog remains, supporting 2026 revenue guidance.
  • Centrus holds a unique position in HALEU supply, relevant to advanced reactor fuel demand.
  • The recommended trade targets a rebound to fairer multiples while emphasizing defined risk controls.
  • ADARx priced 26.25 million shares at $17 each, raising about $446.3 million in its Nasdaq IPO under ticker ADRX.
  • AbbVie agreed to buy up to $100 million of ADARx stock in a private placement, potentially lifting proceeds to $535.2 million.

Latest Articles

SEALSQ and Quobly Sign $5 Million Commercial Agreement to Integrate Post-Quantum Security into Next-Generation Silicon Quantum Computing Platforms

SEALSQ and Quobly Sign $5 Million Commercial Agreement to Integrate Post-Quantum Security into Next-Generation Silicon Quantum Computing Platforms

SEALSQ Corp (NASDAQ: LAES) and Quobly have signed a $5 million commercial agreement to integrate SEALSQ's post-quantum security technologies into Quobly's silicon-based quantum computing platforms. This deal marks the transition from strategic collaboration to commercial deployment, aiming to embed advanced cybersecurity directly into quantum compu…

SL Science Holding Limited Submits Orphan Drug Designation Request to the U.S. FDA for GDT Cell Therapy Targeting Glioblastoma

SL Science Holding Limited Submits Orphan Drug Designation Request to the U.S. FDA for GDT Cell Therapy Targeting Glioblastoma

SL Science Holding Limited has submitted an Orphan Drug Designation request to the U.S. FDA for its Vdelta2+ Gamma Delta T cell therapy aimed at treating glioblastoma multiforme, a highly aggressive brain cancer. This regulatory milestone underscores the company's innovative immunotherapy platform that bypasses conventional limitations in treating …

VYNE Therapeutics Declares Special Cash Dividend in Connection with the Proposed Merger with Yarrow Bioscience

VYNE Therapeutics Declares Special Cash Dividend in Connection with the Proposed Merger with Yarrow Bioscience

VYNE Therapeutics declared a special cash dividend of approximately $16.5 million ($0.38 per share) payable to shareholders prior to the closing of its proposed merger with Yarrow Bioscience. The merger aims to combine VYNE's inflammatory and immune-mediated conditions therapies with Yarrow's autoimmune thyroid disease-focused pipeline, pending sha…

Woodward Named to TIME’s America’s Best Companies 2026 List

Woodward Named to TIME’s America’s Best Companies 2026 List

Woodward, Inc., a Nasdaq-listed company and global leader in aerospace and industrial energy control solutions, was named to TIME's America's Best Companies 2026 list. The recognition highlights Woodward's strong employee satisfaction, financial performance, and commitment to environmental, social, and governance (ESG) principles. This marks contin…

Credo (CRDO): Buy the AI Connectivity Story on Post-Rally Consolidation

Credo (CRDO): Buy the AI Connectivity Story on Post-Rally Consolidation

Credo Technology is converting raw AI bandwidth demand into outsized revenue growth through SerDes chiplets and optical connectivity. Recent results and insider conviction support further upside, but the stock carries a high valuation and concentrated customer exposure. This trade idea proposes a mid-term long with a disciplined stop below the 50-d…

IEA Lowers Russia Oil Output Forecast After Surge in Ukrainian Drone Attacks

IEA Lowers Russia Oil Output Forecast After Surge in Ukrainian Drone Attacks

The International Energy Agency has reduced its projection for Russian crude oil production, citing an escalation of Ukrainian drone strikes on energy infrastructure. The IEA now expects output of 8.9 million barrels per day (bpd) this year - a 3% decline - and 8.8 million bpd in 2027, adjusting its forecasts downward by 85,000 bpd for this year an…

Behind Meta’s Rally: It’s the Infrastructure Math, Not the New AI Model

Behind Meta’s Rally: It’s the Infrastructure Math, Not the New AI Model

A leaked internal memo detailing Meta’s planned compute capacity and apparent cost efficiencies has shifted Wall Street sentiment. Analysts at BofA view the memo’s capacity roadmap and implied per-GW costs as evidence Meta is building AI infrastructure far more cheaply than previously estimated, prompting renewed bullishness despite attention on so…

WRAP Technologies Insider Activity and Strategic Expansion

WRAP Technologies Insider Activity and Strategic Expansion

Scot Cohen, Executive Chairman and CEO of WRAP Technologies, Inc. (NASDAQ:WRAP), recently increased his stake in the company through a significant stock purchase, according to an amended filing with the Securities and Exchange Commission. On July 8, 2026, Mr. Cohen acquired 209,353 shares of WRAP Technologies common stock. The shares were purchased…

YXT.com Announces ADS Ratio Change to Be Effective on July 14, 2026

YXT.com Announces ADS Ratio Change to Be Effective on July 14, 2026

YXT.com Group Holding Limited will change its ADS ratio from one ADS representing three ordinary shares to one ADS representing thirty ordinary shares, effectively a one-for-ten reverse ADS split. This will take effect on July 14, 2026, with the ADS trading price expected to adjust proportionally. No ordinary shares will be issued or cancelled, and…

NorthStrive Biosciences to Advance EL-22 Manufacturing Characterization with Quantitative FACS Analysis of Latent Myostatin Antigen Expression

NorthStrive Biosciences to Advance EL-22 Manufacturing Characterization with Quantitative FACS Analysis of Latent Myostatin Antigen Expression

NorthStrive Biosciences, a subsidiary of PMGC Holdings Inc. (NASDAQ: ELAB), announced plans for an independent flow cytometry (FACS) analysis to quantitatively measure latent myostatin antigen expression on their engineered Lactobacillus casei therapeutic candidate EL-22. This study aims to establish manufacturing comparability against previously p…

BiomX: Zorronet Completes Transition to New Advanced Data Center Supporting Business Expansion and Enhanced AI Capabilities

BiomX: Zorronet Completes Transition to New Advanced Data Center Supporting Business Expansion and Enhanced AI Capabilities

BiomX Inc. announced that its subsidiary Zorronet has successfully transitioned to a new advanced data center designed to enhance AI-powered command-and-control systems for defense, security, and critical infrastructure. The upgraded infrastructure improves real-time threat detection, response times, and scalability, supporting Zorronet's business …

OCC Grants Circle National Trust Charter, Driving Premarket Jump in Shares

OCC Grants Circle National Trust Charter, Driving Premarket Jump in Shares

Circle has secured a final charter from the U.S. Office of the Comptroller of the Currency to form a national trust bank. The approval permits Circle to serve as custodian for its reserves and to custody crypto assets for institutional clients, places the entity under direct federal oversight, and coincided with a roughly 10% rise in the company’s …

Barrick to Report Second Quarter 2026 Results on August 10

Barrick to Report Second Quarter 2026 Results on August 10

Barrick Mining Corporation will release its financial results for the second quarter of 2026 on August 10, prior to market open. The company's management will host a live webcast presentation and Q&A session with analysts to discuss the results. Barrick is a leading global gold and copper mining company, with operations spanning multiple countries …